Every year, millions of patients arrive at emergency rooms with chest pain, yet many remain in a diagnostic gray zone that requires additional testing and hospital resources.
At SandboxAQ, the AQMed team is developing magnetocardiography (MCG), a technology that measures the magnetic fields generated by the heart. By aiming to provide physicians with additional information, MCG has the potential to help clinicians make faster, more confident decisions about patient care.
In this video, Kit Au-Yeung, General Manager of AQMed, discusses:
-The challenge of evaluating chest pain in the emergency room -How MCG works -The potential impact of MCG on patients and healthcare systems -What it takes to bring a novel medical technology from research to clinical care -Why mission-driven teams are essential to solving complex healthcare challenges
The AQMed team is committed to building technology that could improve patient outcomes and touch millions of lives around the world.
The AQMed device is investigational and is not yet FDA-cleared.
